Residency · Residency · Obstetrics Gynecology
First Trimester Prenatal Care and Risk Stratification
Overview
The initial prenatal visit is the foundation for pregnancy management and risk stratification. Ideally, it occurs at 6 to 10 weeks of gestation, with earlier contact arranged for high-risk patients. This visit establishes accurate dating, identifies medical and obstetric risk factors, initiates screening, and builds the patient-provider relationship. The average prenatal visit schedule follows a predictable pattern: every four weeks until 28 weeks, every two weeks until 36 weeks, and then weekly until delivery.
Establishing Gestational Age and Dating
Dating Criteria Hierarchy
Accurate pregnancy dating underpins virtually every subsequent clinical decision. The last menstrual period (LMP) is the starting point, with the estimated due date (EDD) calculated using Naegele's rule: LMP plus 7 days, minus 3 months, plus 1 year. However, first-trimester ultrasound is the most accurate dating method. Crown-rump length (CRL) is measured between 7 and 13 weeks and 6 days, with an accuracy of plus or minus 5 to 7 days. If ultrasound dating differs from LMP by more than 5 days before 9 weeks and 0 days, or by more than 7 days between 9 weeks and 0 days and 13 weeks and 6 days, the ultrasound date should be used. Second-trimester ultrasound dating carries an accuracy of plus or minus 10 to 14 days, while third-trimester dating is only accurate to plus or minus 21 days -- the EDD should never be changed based on third-trimester ultrasound.
Indications for First-Trimester Ultrasound
A first-trimester ultrasound is indicated when the LMP is uncertain or menses are irregular, when vaginal bleeding or pelvic pain is present, when there is a discrepancy between uterine size and dates, when there is a history of ectopic pregnancy, in pregnancies conceived through assisted reproduction (where dating is based on transfer date), when multiple gestation is suspected, and for nuchal translucency measurement between 11 and 13 weeks and 6 days.
Initial Prenatal Visit Structure
Comprehensive History
The history should cover obstetric details including gravity, parity, prior complications (preeclampsia, preterm birth, gestational diabetes, cesarean delivery, stillbirth), delivery modes, birth weights, and neonatal outcomes. The medical history should address chronic conditions such as hypertension, diabetes, thyroid disease, asthma, epilepsy, autoimmune disorders, and psychiatric illness, along with surgical history. All current medications must be reviewed for teratogenic potential. Family history should explore genetic conditions, birth defects, intellectual disability, and thrombophilias. The social history should include tobacco, alcohol, and substance use, intimate partner violence screening, employment, support systems, and housing. Infectious history should cover STIs, TB exposure, and travel to Zika-endemic areas.
Physical Examination
The physical exam begins with vital signs, including a baseline blood pressure that will serve as a critical reference point for later preeclampsia assessment. BMI is calculated, and weight gain counseling is provided according to IOM guidelines. A complete physical exam includes thyroid, breast, cardiac, and abdominal examination. The pelvic exam involves cervical inspection, a bimanual exam to assess uterine size and adnexal masses, and a Pap smear if due per screening guidelines.
Baseline Laboratory Panel
| Test | Rationale |
|---|---|
| CBC | Anemia screening, baseline platelet count |
| Blood type and Rh | Rh status for anti-D prophylaxis planning |
| Antibody screen | Detect alloantibodies (anti-Kell, anti-Duffy, etc.) |
| Rubella IgG | Immunity status; vaccinate postpartum if non-immune |
| Hepatitis B surface antigen | Vertical transmission prevention |
| HIV | Universal screening; HAART reduces transmission to <1% |
| Syphilis (RPR/VDRL) | Rising rates; congenital syphilis prevention |
| Urine culture | Asymptomatic bacteriuria treatment reduces pyelonephritis risk |
| Urinalysis | Proteinuria, glucosuria baseline |
| Pap smear | If due per age-appropriate screening |
| Chlamydia/Gonorrhea (NAAT) | Screen all patients < 25 years; risk-based in older patients |
| Varicella IgG | If immunity status unknown |
| TSH | Consider universal screening vs. risk-based (controversial) |
| Hemoglobin electrophoresis | If not previously screened or at-risk ethnicity |
Additional Testing Based on Risk
Hepatitis C antibody screening is now universally recommended by AASLD and CDC. Urine toxicology may be considered with patient consent if substance use is suspected. Lead levels should be checked in at-risk populations or those with occupational exposure. Vitamin D levels are worth considering in dark-skinned individuals or those with limited sun exposure. An A1C or early glucose screening should be ordered when risk factors for pregestational diabetes are present. TB testing is appropriate in high-risk populations.
Early Pregnancy Viability Assessment
Normal Early Pregnancy Landmarks
The gestational sac becomes visible at approximately 5 weeks, corresponding to a beta-hCG level of roughly 1,500 to 2,000 mIU/mL on transvaginal ultrasound. The yolk sac appears at about 5.5 weeks. An embryonic pole with cardiac activity is typically seen at around 6 weeks, when the CRL measures 2 to 4 mm. The normal embryonic heart rate starts at 100 to 120 bpm at 6 weeks and rises to 140 to 170 bpm by 8 weeks.
Criteria for Nonviability (ACOG/SRU Consensus)
Nonviability can be diagnosed when a CRL of 7 mm or greater is seen with no cardiac activity, or when the mean sac diameter is 25 mm or greater with no embryo visible. It is also diagnosed when no embryo with heartbeat appears at least 2 weeks after a scan showing a gestational sac without a yolk sac, or at least 11 days after a scan showing a gestational sac with a yolk sac. When findings are indeterminate, the ultrasound should be repeated in 7 to 14 days before diagnosing pregnancy failure.
Threatened Miscarriage
Threatened miscarriage -- defined as vaginal bleeding with a closed cervix and a viable intrauterine pregnancy -- occurs in 20 to 25% of pregnancies. Approximately 50% of these pregnancies will continue to term. No proven intervention improves the outcome, though progesterone supplementation remains debated, as explored in the PRISM trial.
Risk Stratification
Identifying High-Risk Pregnancies
Obstetric risk factors include prior preeclampsia, preterm birth, cesarean delivery, stillbirth, intrauterine growth restriction, gestational diabetes, cervical insufficiency, and alloimmunization. Medical risk factors encompass chronic hypertension, pregestational diabetes, lupus and antiphospholipid syndrome, renal disease, cardiac disease, thrombophilia, a BMI of 40 or greater, and advanced maternal age (35 or older). Social risk factors include substance use, intimate partner violence, limited prenatal care access, and adolescent pregnancy. Genetic risk factors include known carrier status, a family history of genetic conditions, and a prior affected child.
Risk-Based Care Pathways
Low-risk patients follow a standard prenatal visit schedule with routine screening. High-risk patients receive increased surveillance, maternal-fetal medicine (MFM) consultation, and adjusted visit frequency. Conditions warranting MFM referral include pregestational diabetes, chronic hypertension with end-organ damage, prior stillbirth or recurrent pregnancy loss, multiple gestation, suspected fetal anomaly, prior preterm birth before 34 weeks, and significant cardiac or renal disease.
First-Trimester Counseling Topics
Counseling at the first visit should cover expected pregnancy symptoms and when to call the provider. Dietary guidance includes avoiding raw or undercooked meats, unpasteurized dairy, high-mercury fish, and deli meats (due to Listeria risk). Exercise should be continued or initiated at moderate intensity, targeting 150 minutes per week. Travel is generally safe until 36 weeks, with certain air travel considerations. Sexual activity is safe in uncomplicated pregnancies. An overview of genetic screening options should be provided, with a more detailed discussion planned for 10 to 13 weeks. Workplace and environmental exposures should be reviewed. Dental care is safe and encouraged, as periodontal disease has been associated with preterm birth.
<image> A detailed flowchart illustrating the first prenatal visit algorithm. Beginning with "Patient presents for initial prenatal visit," the chart branches into history taking, physical examination, and laboratory panel ordering. A parallel branch shows the dating algorithm: LMP known vs. unknown, ultrasound dating criteria, and decision rules for which date to use. The bottom portion shows risk stratification categories (low, moderate, high) with corresponding care pathway recommendations and referral triggers. </image>
<image> A series of four transvaginal ultrasound illustrations showing normal early pregnancy landmarks in sequence. Panel A shows a gestational sac at 5 weeks with labeled endometrium and decidual reaction. Panel B shows a gestational sac with yolk sac at 5.5 weeks. Panel C shows an embryo with cardiac activity at 6.5 weeks with CRL measurement caliper placement demonstrated. Panel D shows a 12-week fetus with labeled anatomy including head, body, and limb buds. Each panel includes the corresponding beta-hCG range and gestational sac measurements. </image>
<image> An infographic-style medical illustration comparing viability and nonviability criteria in early pregnancy. The left column shows "Findings consistent with viable pregnancy" with illustrations of normal gestational sac growth, yolk sac appearance, and embryonic cardiac activity. The right column shows "Diagnostic criteria for pregnancy failure" with illustrations of empty sac >= 25mm, CRL >= 7mm without cardiac activity, and absent growth on serial scans. A central column shows "Indeterminate findings requiring follow-up" with recommendations for repeat imaging intervals. </image>
Key Clinical Pearls
The EDD should never be changed after 22 weeks; early and accurate dating is essential for all subsequent clinical decisions. Treatment of asymptomatic bacteriuria in pregnancy reduces the risk of pyelonephritis from approximately 30% to about 3%. A single elevated blood pressure reading at the first visit does not diagnose chronic hypertension -- the measurement should be confirmed on repeat, but it must be documented carefully. Early pregnancy bradycardia (a heart rate below 100 bpm at 6 to 7 weeks) is associated with an increased risk of subsequent pregnancy loss. Universal hepatitis C screening is now recommended in pregnancy by multiple organizations. The first prenatal visit is an ideal time to discuss emergency contraception and birth spacing for the postpartum period. Rh status should always be confirmed early, as anti-D immunoglobulin planning begins at the first visit.
References
- ACOG Committee Opinion No. 700: Methods for Estimating Due Date (2017, reaffirmed 2023)
- ACOG Practice Bulletin No. 228: First Trimester Risk Assessment for Early-Onset Preeclampsia (2021)
- Doubilet PM et al. Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester. N Engl J Med. 2013;369:1443-1451
- ACOG Committee Opinion No. 808: Routine Hepatitis C Virus Screening in Pregnant Individuals (2020)
- USPSTF Screening Recommendations for Pregnancy (updated 2023)
